��������

Stanislava Milosevic is a highly experienced professional in the field of drug safety and pharmacovigilance, currently serving as a Principal Drug Safety Associate and Pharmacovigilance Specialist at PRA Health Sciences since April 2018. In this role, Stanislava leads drug safety initiatives for oncology and rare disease clinical and post-marketing studies and coordinates pharmacovigilance operations at a project level. Previous positions include Drug Safety Associate III and II at the same organization, along with roles as a Clinical Research Coordinator at Northwestern University and Rush University Medical Center, and as a Surgical Assistant at NuHart Clinics and Belmont Central. Stanislava began a medical career as a Medical Doctor at the Clinical Center of Serbia. Stanislava holds an MD degree from the University of Belgrade, School of Medicine.